Drug approved to help young patients battle a rare cancer
Children and adults with a rare type of soft tissue cancer will now have a new treatment option that could have a big impact.
Jan 2, 2023
0
4
Children and adults with a rare type of soft tissue cancer will now have a new treatment option that could have a big impact.
Jan 2, 2023
0
4
Even as they've revolutionized cancer treatment, drugs known as immune checkpoint inhibitors can produce a range of adverse, immune-related side effects. In a new study, scientists at Dana-Farber Cancer Institute identify, ...
Dec 16, 2022
0
104
Scientists at Duke-NUS Medical School have identified a gene that controls the behavior of a specific type of cardiac macrophage responsible for excessive scarring during the early phases of common heart diseases or cardiomyopathies. ...
Dec 9, 2022
0
77
To prevent testing on animals and create even more precise ways of testing therapeutics, the pharmaceutical industry is increasingly turning to human immune cells. However, the availability of cells like these has been limited ...
Dec 1, 2022
0
2
In a step likely to advance personalized cancer treatment, scientists have—for the first time—shown in patients that levels of biomarkers are not enough to tell which patients are likely to respond best to immunotherapy.
Nov 22, 2022
0
69
Individuals previously infected with SARS-CoV-2, the virus that causes COVID-19, still benefit from vaccination, gaining 60% to 94% protection against reinfection, depending on the variant. A new study led by Katrine Finderup ...
Nov 22, 2022
0
41
A cup of ruby red hibiscus tea not only warms the body in winter but is also known to boost the immune system, control blood pressure, and reduce body weight. And here is yet another reason to enjoy this tea—it may help ...
Nov 16, 2022
0
41
COVID-19 reactivated viruses that had become latent in cells following previous infections, particularly in people with chronic fatigue syndrome, also known as ME/CFS. This is the conclusion of a study from Linköping University ...
Nov 16, 2022
0
103
A new study shows that when an experimental cancer medication is split in half, the molecule becomes safer and more effective.
Nov 11, 2022
0
55
Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. Until now, it was feared that vaccination against COVID-19 could reduce the success of cancer treatment ...
Nov 8, 2022
0
5